プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Barry B.に依頼

Canada

Senior molecular biologist with a background in experimental oncology, mitochondria toxicology and environmental health.

プロフィール概要

Barry J Barclay Ph D is President/CEO of SunHealthRx Inc. based in St Albert, Alberta Canada. Barry designed and was the first Coordinator of the After-degree Program in Environmental Health at Concordia University College of Alberta. Previously he held faculty appointments in Molecular Biology and/or Experimental Oncology at Cariboo College (now Thompson Rivers University), University of Alberta, Cross Cancer Institute, Brock University, York University, and the Department of Biochemical Pharmacology at the State University of New York at Buffalo.

専門分野

• ★ Skin Cancer
• ☆ Environmental Health
• ☆ Carcinogenesis

サービス

• Writing
• Research

Writing Clinical Trial Documentation, Technical Writing, Newswriting

Research Fact Checking, Systematic Literature Review, Secondary Data Collection

職務経験

President & CEO

SunHealthRx Inc

10月 2016 - 現在

President & CEO

Planet Biotech

6月 1998 - 現在

学歴

Ph D (Biology)

York University

6月 1975 - 5月 1978

BSc (hons)

York University

9月 1971 - 5月 1975

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2018). Mitochondrial Correction: A New Paradigm for Cancer and Degenerative Diseases. Journal of Orthomolecular Medicine.

Narayanan KB, Ali M, Barclay BJ, Cheng QS, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, Ratovitski E, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-Temaimi R, Carcinogenesis, 2015, vol. 36 Suppl 1, pp. S89-110 .

Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Carcinogenesis, 2015, vol. 36 Suppl 1, pp. S254-96 .

Barclay BJ, DeHaan CL, Hennig UG, Iavorovska O, von Borstel RW, von Borstel RC, Environmental and molecular mutagenesis, 2001, vol. 38, no. 2-3, pp. 153-158 .

Barclay BJ, Nagel MG, Huang T, Advances in experimental medicine and biology, 1993, vol. 338, pp. 551-554 .

Barclay BJ, Ondrusek NK, Wildenhain YD, Huang T, Carlone RL, Clement JM, Wahl GM, Advances in experimental medicine and biology, 1993, vol. 338, pp. 545-550 .

Huang T, Barclay BJ, Kalman TI, von Borstel RC, Hastings PJ, Gene, 1992, vol. 121, no. 1, pp. 167-171 .

Barclay BJ, Huang T, Nagel MG, Misener VL, Game JC, Wahl GM, Gene, 1988, vol. 63, no. 2, pp. 175-185 .

Taylor GR, Barclay BJ, Storms RK, Friesen JD, Haynes RH, Molecular and cellular biology, 1982, vol. 2, no. 4, pp. 437-442 .

Barclay BJ, Kunz BA, Little JG, Haynes RH, Canadian journal of biochemistry, 1982, vol. 60, no. 3, pp. 172-184 .

Moens PB, Barclay BJ, Little JG, Chromosoma, 1981, vol. 82, no. 3, pp. 333-340 .

Kunz BA, Barclay BJ, Haynes RH, Mutation research, 1980, vol. 73, no. 1, pp. 215-220 .

Kunz BA, Barclay BJ, Game JC, Little JG, Haynes RH, Proceedings of the National Academy of Sciences of the United States of America, 1980, vol. 77, no. 10, pp. 6057-6061 .

Barclay BJ, Little JG, Molecular & general genetics : MGG, 1978, vol. 160, no. 1, pp. 33-40 .

Barclay BJ, Little JG, Journal of bacteriology, 1977, vol. 132, no. 3, pp. 1036-1037 .

CONFERENCE PAPER

(2017). Thymidylate Synthetase Dysregulation is a Molecular Switch and Tumorigenic Driver in Early Breast Cancer. Primary Therapy of Early Breast Cancer 15th St Gallen International Breast Cancer Conference.